SUBSCRIBE
SUBSCRIBE

Biothera’s Imprime PGG(R) Improves Survival in KRAS Mutant Colorectal Cancer Patients

June 23, 2011 | 
1 min read
BARCELONA--(BUSINESS WIRE)--Biothera will present data from its Phase II clinical trial in stage IV KRAS mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25.
Europe
MORE ON THIS TOPIC
Contemporary art collage. Motivated, confident team go over light background with abstract object, red arrows. Concept of business development, teamwork, startup, finance, career.
Job Trends
Biopharma cuts at manufacturing plants expected to affect 4,000+
October 29, 2026
 · 
5 min read
 · 
Angela Gabriel
3d pharmaceutical world icon with included clipping path.
Opinion
Biotechs going to market alone must learn to go global
October 28, 2026
 · 
3 min read
 · 
Paul Bridges
USD dollar banknote with USA flag and stock market graph chart for currency exchange and global trade forex concept.
Business
US biotechs take lion’s share of $54.5B VC money raised since 2025
October 26, 2026
 · 
1 min read
 · 
Gabrielle Masson
German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor